1. Home
  2. SCKT vs BCDA Comparison

SCKT vs BCDA Comparison

Compare SCKT & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Socket Mobile Inc.

SCKT

Socket Mobile Inc.

HOLD

Current Price

$1.06

Market Cap

7.5M

Sector

Technology

ML Signal

HOLD

BCDA

BioCardia Inc.

HOLD

Current Price

$1.26

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCKT
BCDA
Founded
1992
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
14.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
SCKT
BCDA
Price
$1.06
$1.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
28.0K
72.3K
Earning Date
10-22-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,945,490.00
N/A
Revenue This Year
$8.62
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$1.00
52 Week High
$1.72
$3.20

Technical Indicators

Market Signals
Indicator
SCKT
BCDA
Relative Strength Index (RSI) 36.90 40.27
Support Level $1.24 $1.22
Resistance Level $1.29 $1.38
Average True Range (ATR) 0.05 0.09
MACD -0.03 -0.02
Stochastic Oscillator 6.89 14.29

Price Performance

Historical Comparison
SCKT
BCDA

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: